Biotech/Medical Tech Stock News from Investorideas.com: The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains

Wednesday, August 21, 2024

The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains

The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains: The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains

Investorideas.com (www.investorideas.com) a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Virax Biolabs Group Limited (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases.

The stock is currently trading at $5.25, up $1.69, gaining 47.53%, with a day’s high of $6.36.

Yesterday Zacks Investment Ideas featured highlights Virax Biolabs Group VRAX, GeoVax Labs GOVX, Applied DNA Sciences APDN and Emergent BioSolutions EBS.

“WHO Declares Mpox Public Emergency: 5 Stocks to Watch

The World Health Organization (WHO) is a branch of the United Nations dedicated to health. Founded in 1948, the WHO’s primary roles include supervising and coordinating health programs. The WHO also monitors health trends, establishes guidelines and suggestions, and supports countries that need it. Moreover, the WHO leads efforts to control diseases, improve healthcare systems, and tackle health emergencies and pandemics.”

Read full article

https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-090000627.html

The company has not issued any recent news.

Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.

Research more Biotech stocks with Investorideas.com free stock directory

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: More disclaimer and disclosure info https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp